The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
another article
https://depts.washington.edu/pandemicalliance/2020/11/16/safety-and-efficacy-of-inhaled-nebulised-interferon-beta-1a-sng001-for-treatment-of-sars-cov-2-infection-a-randomised-double-blind-placebo-controlled-phase-2-trial/
apols if already posted
https://www.theguardian.com/commentisfree/2020/oct/21/covid-vaccine-immunisation-protection
insightful article by a former Director of Immunisation at the Dept of Health
Vaccines and treatments will all have their place.....
interesting listen if time allows
https://www.fda.gov/news-events/fda-insight/fda-insight-clinical-trials-and-treatments-covid-19
66% buys to 34% sells over the last week according to HL page (buys/sells ratio section of the page)
https://www.hl.co.uk/shares
Interesting that the BBC are including links to the human challenge trials to encourage sign up. Is it worth suggesting to Synairgen to see if they could also seek some coverage for the home trial sign up. Is the difference that they are a private company and the BBC are promoting a heavily government funded initiative?
https://www.bbc.co.uk/news/health-54612293
JD - saw that and wondered the same, but I am no expert to know what 'normal' levels of side effects might look like.....I suspect that this will simply provide another option for certain people, it was just that AZ have released it and the level of political preference for the big players seems apparent at the mo.....
For anyone interested to read and in relation to the COPD play for SNG - AZ looking good for marketing authorisation on it. Anyone think this affects the fall back COPD value of SNG? - just assessing risk v reward here and value of COVID play and COPD play.
https://www.ema.europa.eu/en/medicines/human/summaries-opinion/trixeo-aerosphere
all thoughts appreciated
B
https://www.gov.uk/government/news/cutting-edge-treatments-to-be-fast-tracked-to-patients-through-international-collaborations
could be interesting
apols if slow on this but first I had heard of safety signals on Remdesivir being raised - are others aware - options potentially narrowing on all vaccine and treatment fronts which is worrying
https://www.reuters.com/article/us-health-coronavirus-gilead-sciences-eu-idUSKBN26N2VO
just over a week to go!
https://www.ii.co.uk/analysis-commentary/who-will-win-big-years-aim-awards-ii513583
https://science.sciencemag.org/content/369/6511/1550?intcmp=trendmd-sci
not sure if preciously posted, apols if so
GLA
might this be a route to approval?
https://www.fda.gov/patients/fast-track-breakthrough-therapy-accelerated-approval-priority-review/breakthrough-therapy